MYC/BCL2 protein coexpression contributes to the inferior survival of activated B-cell subtype of diffuse large B-cell lymphoma and demonstrates high-risk gene expression signatures: a report from The International DLBCL Rituximab-CHOP Consortium Program

Diffuse large B-cell lymphoma (DLBCL) is stratified into prognostically favorable germinal center B-cell (GCB)–like and unfavorable activated B-cell (ABC)–like subtypes based on gene expression signatures. In this study, we analyzed 893 de novo DLBCL patients treated with R-CHOP (rituximab, cyclopho...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hu, Shimin, Xu-Monette, Zijun Y., Tzankov, Alexander, Green, Tina, Wu, Lin, Balasubramanyam, Aarthi, Liu, Wei-min, Visco, Carlo, Li, Yong, Miranda, Roberto N., Montes-Moreno, Santiago, Dybkaer, Karen, Chiu, April, Orazi, Attilio, Zu, Youli, Bhagat, Govind, Richards, Kristy L., Hsi, Eric D., Choi, William W. L., Zhao, Xiaoying, van Krieken, J. Han, Huang, Qin, Huh, Jooryung, Ai, Weiyun, Ponzoni, Maurilio, Ferreri, Andrés J. M., Zhou, Fan, Slack, Graham W., Gascoyne, Randy D., Tu, Meifeng, Variakojis, Daina, Chen, Weina, Go, Ronald S., Piris, Miguel A., Møller, Michael B., Medeiros, L. Jeffrey, Young, Ken H.
Format: Artigo
Idioma:Inglês
Publicat: American Society of Hematology 2013
Matèries:
Plenary Paper
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3709650/
https://ncbi.nlm.nih.gov/pubmed/23449635
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2012-10-460063
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars